Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8657251 | Atherosclerosis Supplements | 2017 | 13 Pages |
Abstract
Despite the lack of prospective randomised trials apheresis these days remains the standard of care in patients with elevated Lp(a) and severe CVD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anja Vogt,